Hepatitis B virus (HBV) reactivation is commonly observed in individuals with chronic HBV infection undergoing antineoplastic drug therapy. Paclitaxel (PTX) treatment has been identified as a ...
Two cross-sectional, one validation cohort, and meta-analyses were used to explore the relationship between HBV replication and liver inflammation. Spearman analysis, multiple linear regression, and ...
FDA regulatory momentum includes priority review and breakthrough therapy designation for a potential first-in-class CHB functional cure, with a PDUFA target date of October 26, 2026. Current ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results